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Abstract
Background: Nigeria has the tenth highest burden of tuberculosis (TB) among the 22 TB high-burden countries in the
world. This study describes the biodiversity and epidemiology of drug-susceptible and drug-resistant TB in Ibadan, Nnewi
and Abuja, using 409 DNAs extracted from culture positive TB isolates.
Methodology/Principal Findings: DNAs extracted from clinical isolates of Mycobacterium tuberculosis complex were studied
by spoligotyping and 24 VNTR typing. The Cameroon clade (CAM) was predominant followed by the M. africanum (West
African 1) and T (mainly T2) clades. By using a smooth definition of clusters, 32 likely epi-linked clusters related to the
Cameroon genotype family and 15 likely epi-linked clusters related to other ‘‘modern’’ genotypes were detected. Eight
clusters concerned M. africanum West African 1. The recent transmission rate of TB was 38%. This large study shows that the
recent transmission of TB in Nigeria is high, without major regional differences, with MDR-TB clusters. Improvement in the
TB control programme is imperative to address the TB control problem in Nigeria.
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Introduction
Multi-drug-resistant Mycobacterium tuberculosis (MDR-TB) has
emerged as a major global public health problem [1]. WHO
estimates that in 2008, between 390,000 and 510,000 persons
developed MDR-TB worldwide with 69,000 cases occurring in
Africa and 11,000 in Nigeria [2]. Nigeria has the tenth highest
burden of TB among the 22 TB high-burden countries and an
estimated TB incidence rate of 320/100000 population (WHO
2011). MDR-TB is an emerging problem in Nigeria with as much
as 8% of all cultured specimens being MDR-TB in Ibadan, Nnewi
and Abuja [2].
Despite the ever growing importance of TB in Nigeria, available
molecular epidemiological studies do not represent an extensive
picture of TB epi-links in this country due to non-standard
genotyping protocols and restricted sampling areas [3–6]. This is
due to molecular diagnostic methods being until now poorly
adapted to high TB prevalence due to high costs or suboptimal
protocols to ensure epi-links detection. Hence, the African TB
molecular epidemiology is poorly described with the exception of
South Africa [7,8].
Recent innovations in molecular diagnostics (e.g. Hain
MTBDRplusH, MTBDRsl H, GenXpertH) and genotyping proce-
dures such as the analysis of 24 Mycobacterial Interspersed
Repetitive Units-Variable Number of Tandem Repeats (MIRU-
VNTR) and high-throughput spoligotyping have made the
analysis of TB transmission more efficient and the MDR-TB
diagnostics easier [9,10]. Multiplexed high-throughput technolo-
gies are also emerging as powerful tools both for molecular
diagnostics and public health with whole genome sequencing
(WGS) holding promise for this field [11,12]. 24 MIRU-VNTR
combined with spoligotyping is a new standard to replace the
IS6110-Restriction Fragment Length Polymorphism (RFLP)
fingerprinting method. Analyzing hundreds and even thousands
of clinical isolates’ DNA with limited resources has now become
feasible [13,14].
Combining spoligotyping and MIRU-VNTR allows to analyze
thegeneticdiversityandmolecularepidemiologyofdrugsusceptible
and MDR-TB strains with the aim to identify the population
structure of circulating clinical isolates, to estimate the recent TB
transmission rate, and to eventually detect the transmission of
MDR-TB cases [2].
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e38409In this manuscript, we present the characterization of the drug-
susceptible and MDR-TB M. tuberculosis isolates previously
reported by Lawson’s et al. (2011) in Nigeria using molecular
markers and we estimate the recent TB transmission rate in
Nigeria [2]. We also identify the main clades of circulating
genotypes.
Materials and Methods
Biological Samples, Clinical Isolates, Drug Susceptibility
Testing, DNA Extraction
Sputum specimens were obtained through a cross-sectional
study aiming at describing TB drug resistance in three cities of
Nigeria. These are cities situated in three different geopolitical
zones of Nigeria, as reported in Lawson et al., 2011 [2]. Five
hundred twenty patients were recruited (520), including 433 newly
diagnosed patients with pulmonary TB (PTB) and 87 patients with
PTB who had failed to respond to first-line TB treatment
attending TB diagnostic centres in three different geopolitical
zones of Nigeria. Patients over 18 years old with positive smear
microscopy attending Directly Observed Treatment Short course
(DOTS) treatment centres were enrolled prospectively from
August 2009 to July 2010 at 1) Wuse, Maitama, Asokoro and
Nyanya General Hospitals in Abuja, 2) the University College
Hospital and five DOTS centres in Ibadan and 3) Nnamdi
Azikiwe Teaching Hospital and three DOTS centres in Nnewi.
Clinical features of these specimens were described in Lawson et al.
[2]. The protocol for the study received Ethical approval from the
Federal Capital Territory Health and Research Ethics Committee
and Zankli Ethical Research Review Board. Written consent was
obtained from all participants including permission to store
samples to conduct further tests for characterising the strains
affecting them.
Drug Susceptibility Tests were Performed in Liquid (BactecHM-
GIT960 System, Becton Dickinson, NJ) Media for 426 Culture-
positive Mycobacterium Tuberculosis Complex (MTBC) of the 520
Participants (82%) with Smear-positive Sputum Samples.
DNA was extracted from isolates derived from sputum
specimens cultured on BACTECH MGIT960 by a thermolyzate
method and sent by express carrier on ice to the Institut de
Ge ´ne ´tique et Microbiologie UMR8621 CNRS-University Paris-
Sud.
Genotyping Methods, Data Analysis
High-throughput spoligotyping was performed on Luminex
200H (Luminex Corp., TX) as previously described [15]. Twenty-
four VNTR loci analysis was done on agarose gels after simplex
PCR, as previously reported [16], or using an updated in house
duplex procedure (Refre ´gier et al. unpublished data). The
standardized 24 VNTR loci method was used [10]. DNA was
available for 423 isolates (353 from new cases and 70 from
previously treated patients); complete genotyping defined as
spoligotyping plus at least 20 MIRU-VNTR markers was obtained
for 404 samples (97%). From these, 154 were obtained from Abuja
(38%), 81 from Ibadan (20%) and 169 from Nnewi (42%). All data
were entered into ExcelH files and transferred to BionumericsH
(v.6.6 Applied Maths, Sint Martin Latems, Belgium). Cluster
analysis was performed in BionumericsH according to instructions
manual (Figure 1, 2, 3, 4). Clade/Family assignation was done
based on SpolDB4 for available Spoligo-International-Types (up
to SIT1939) and based on SITVITWEB for SIT nu 2088 and
2550 [17,18]. MIRU-VNTR international type (MIT) designation
was done using SITVITWEB [18]. When no SIT nu were
available in SpolDB4 or SITVITWEB, the designation ‘‘new-x’’
(lower cases) was given for orphan pattern and the designation
‘‘NEW-X’’ for new intra-study clusters. The recent transmission
Index (RTI) was computed using the (n21) method in which the
number of isolates in clusters minus the number of clusters divided
by the total number of isolates represents the recent tuberculosis
transmission rate; in our case: (RTn-1=152–51/410) [19].
Statistical analyses (Odds ratio, Chi-square and Student’s T test
and ANOVA) were performed in R version 2.13.0 (www.r-project.
org/).
Results
Population Description
MTBC strains were isolated from 423 patients (163 men, 253
women, and 7 with unregistered gender). Twenty-three patients
were ,20 years old, 289 between 20 and 40 years, 87 between 40
and 60 years and 17.60 years old.
M. tuberculosis Complex Genetic Diversity in Nigeria
Studied by Spoligotyping
Spoligotyping results (43 spacers format) were obtained for 412
of 423 (97%) isolates (Fig 1, 2, 3, 4 and Table S1). The global
population structure is made up of 4 main clusters: one from the
Cameroon clade (CAM), two from the Mycobacterium africanum West
African 1, and one from other ‘‘modern’’ clinical isolates (Figure 1).
Seventy-one different spoligotypes were identified (Figures 2, 3, 4
and Table S1). Thirty-five of these patterns were unique and 36
occurred in clusters totaling 377 isolates, containing a range of 2 to
208 isolates. The CAM family (formerly designated as Latin
American and Mediterranean-10-CAM or LAM-10-CAM) pre-
dominated, with 269 isolates (65%), of which 261 clustered and 8
were orphans). M. africanum West African 1 represented 53 isolates
(13%) of the isolates with 42 clustered and 11 orphans. Other
genotype families were: 1) ‘‘modern’’ strains including T2 (n=29;
7%), Haarlem (n=31; 7%), and Latin-American-Mediterranean
(LAM) (n=2; 0.5%), 2) Beijing (n=1; 0.25%), 3) Mycobacterium
bovis (n=4; 1%) and 4) other unclassified isolates (n=12; 3%).
Most CAM family isolates (n=208, 77%) had the SIT61; 10 other
CAM-related spoligotype profiles were identified (Table 1):
SIT838 found in 19 isolates (7%), further 4 SIT types containing
from 1 to 4 isolates and 6 undesignated types in the SpolDB4
worldwide database [17] shared by 2 to 6 isolates and 7 orphan
patterns. The four spoligotype profiles characteristic of M. bovis
showed the absence of spacer 30 which is a specific characteristic
of the ‘‘African 1’’ M. bovis genotype family previously described as
predominant in Western Central Africa (Nigeria, Cameroun,
Mali, Chad) [20]. By comparison with the M. bovis database (www.
mbovis.org, see also Table 1), three isolates matched with known
profiles SB0944 (SIT1037), SB1026 (new-h), SB1099 (new-d), and
one isolate (new-b) had not been previously described.
53 M. africanum isolates were found. 52 lacked spacers 8–12 and
37–39 and thus belonged undoubtedly to M. africanum West
African 1 (MAF1) [21]. The largest cluster within MAF1 was
ST331, with 13 isolates. One isolate from Abuja (‘‘new-s’’)
exhibited a partial signature of MAF1 (absence of spacers 37–39
but presence of spacers 8 and 10–12 [21]. Spoligotyping on an
additional 25 spacers set (68 spacers spoligotyping) unfortunately
did not much improve the clusterization of all clinical isolates
(Table S1).
24 VNTR Results; Recent Transmission Index Assessment
Exploitable VNTR results (defined as less than 4 missing values)
were obtained for 404 of 423 isolates (Table S1). Some isolates did
not provide results for many loci. Among the most problematic
Molecular and Genetic Diversity of TB in Nigeria
PLoS ONE | www.plosone.org 2 June 2012 | Volume 7 | Issue 6 | e38409loci, Mtub39 (VNTR3690) characterisation frequently failed
(n=78). The failure to amplify Mtub39 was linked to isolates
belonging to the CAM family suggesting an amplification problem
specific to this family (Odds Ratio=4.8; IC95=[2.5; 10.1]).
Recent results in Indian isolates have pointed to the large
variability of copy number of VNTR3690 [22]. A similar
observation was made for the 57 isolates in which there was a
failure to amplify QuB11b (VNTR2163b), among which all M.
africanum. None of the 53 M. africanum clinical isolates provided
results on QuB11b whereas only 20 among the 370 other strains
did not (x
2268). As this feature seems to rely on genetic properties
of all M. africanum isolates, QuB11b marker was hypothesized to be
identical (‘‘X’’ or not determined ‘‘ND’’ in Table S1) for all isolates
from this group. Finally, 45 isolates failed to amplify for MIRU16,
23 of which belong to the M. africanum and M. bovis clade
(OR=6.4; IC95=[3.3; 12.6]).
Sub-populations were tentatively identified among CAM
isolates using spoligotyping and 24 VNTR. The identified clusters
exhibited 20, 16, 21, 26, 15,16 and 4 clinical isolates respectively
(Table 2). A large proportion of CAM isolates could not be
amplified for Mtub39 locus. The remaining isolates had a
surprisingly diverse copy numbers. The values ranged from 2 to
28 copies and are noted as ‘‘N’’ (Table 2) (cf. also Table S1).
Spoligotyping splits the CAM sub-group G-V isolates into two sub-
clusters of 15 and 16 isolates. Among ‘‘Unknown’’ isolates
according to SpolDB4, six sharing the spoligotype SIT1204
shared 24 VNTR patterns suggesting a phylogenetic link with
CAM family. The SIT1204 genotype was already described in the
Cross River State in the South geopolitical zone of Nigeria [4].
These strains differed only on the Mtub39 locus and harboured an
intermediate copy number (n=2.5 copies) at the exact tandem
repeat D (ETR-D) locus [23]. They may represent an epi-cluster.
If defining clusters by using 100% identity between isolates
according to both spoligotyping and VNTR typing, and consid-
ering missing values as unique so that any pattern with a missing
value cannot belong to a cluster, 134 isolates were grouped in 47
clusters containing 2 to 11 isolates. If these figures are considered a
true representation of the epidemiological situation and using the
(n21) method, the recent TB transmission rate would be around
22% in Nigeria [19]. However when single-variants are included,
the number of clusters doubles reaching 219 isolates grouped in 65
clusters and a Recent Transmission Index (RTI) of 38% (Table 3).
The analysis using VNTR genotyping data alone did not give
significantly lower discriminatory power than the composite one,
i.e. adding spoligotyping information (Table 3).
Amplification for QuB11b did not work for M. africanum isolates
and clustering analysis was thus conducted without this marker. A
high polymorphism of MLVA (multi-locus VNTR analysis) was
observed within M. africanum clinical isolates DNA with identical
spoligotypes, suggesting that spoligotyping-based clustering repre-
sented common ancestors with no clear epidemiological links in
most cases. Indeed, among the 49 M. africanum isolates for which
Figure 1. Minimum Spanning Tree (MST) of all available spoligotypes (n=408; Nnewi n=172 green colour, Abuja n=154 red
colour, Ibadan, n=82 blue colour), constructed and drawn using Bionumerics (v.6.6, Applied Maths, Sint-Martens-Latem, Belgium)
and the ‘‘advanced cluster analysis’’ method. Some prevalent clades are designated and identified using Spoligotype-International-Types (SIT).
Main Clades (Cameroon, M. africanum West African 1, modern ‘‘T’’ are also shown.
doi:10.1371/journal.pone.0038409.g001
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identified using a strict cluster definition (100% identity). VNTR
clusters were also found in the T and H families (Table S1) with six
out of eight SIT53 (T1) isolates found in one single cluster.
Amongst the 41 SIT52 or derived types, also designated as Ghana
family, and using 100% identity, only 17 isolates were found in 4
clusters (4 SIT2088, 4 SIT846, 5 designated as ‘‘NEW3’’ and 4
designated as ‘‘NEW5’’). 11 of 13 SIT316 isolates (T2-variant)
were found in one cluster, whereas two other isolates differed on
only one single VNTR locus, Miru26 [24]. These two isolates are
likely to represent a second epidemiologically-linked cluster.
An Evolutionary Scenario of the ‘‘Cameroon’’ (CAM)
Clade
The CAM clade, was first described in Cameroon and shows a
typical SIT61 signature [25,26]. The MLVA analysis of the
Figure 2. Unweighted Pair Group Method using Mathematical Averages (UPGMA) dendrogram (first column) built with
BionumericsH on a composite data set (24 VNTR-largest column)-Spoligotyping (coloured column) on the clinical isolates from
Abuja patients. (identification number : last column) Main Clades are also annotated right to identification number.
doi:10.1371/journal.pone.0038409.g002
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logic information and together with the 43 spacers spoligotyping,
describes a global population analysis of at least 7 main clusters.
The combination of values obtained on MIRU16 and MIRU40
(greyed out numbers in following text) allows the observation of
three main MIRU12 international types (MIT) as described in
the SITVITWEB database (see http://www.pasteur-guadeloupe.
fr:8081/SITVIT_ONLINE): 223315153323, reported as MIRU-
international-type 12 (MIT12), 223315153321, reported as
MIT266 and 223215153323, reported as MIT264. All three
major VNTR 12 types were independently reported in Nigeria in
another study [4]. QuB11B provides further epidemiological
information within the sub-clades (Table 2). Assuming a
molecular evolution by loss of copies on MIRU40, the ancestral
character of this marker would be 3 and the ancestral MIT
signature would be MIT12, which would have independently
evolved in MIT264 and MIT266. The larger diversity observed
in Mtub39 for MIT12 and MIT266 (from 5 to 28 copies, see
also Table S1) than for MIT264 (from 10 to 12 copies) reinforces
this hypothesis.
Distribution of Multi-Drug Resistance Isolates
Twenty-nine (29 i.e. 7%) of 407 isolates with phenotypic Drug
Susceptibility Testing (DST) in BACTEC-MGITH (Becton
Dickinson, NJ, USA) were MDR-TB isolates as previously
described [2]. Among these, 23 belonged to the CAM family, of
which 17 were SIT61 (data not shown). The proportion of
MDR-TB within the CAM family is statistically not different
from the percentage of the CAM family in the whole
population (Student’s test T=0.1; df=260; p-value=0.9). Three
MDR-TB isolates belonged to T, one to LAM, one to M.
africanum and one to U (Unknown). Nine MDR-TB isolates
belonged to the subgroup G-III of the CAM family which
contains 21 isolates (i.e. 43% MDR in this subgroup). Nine
additional isolates were resistant to at least one of the drugs
tested (altogether 85% of resistance). The CAM and T clades
exhibited a high resistance level with respectively 53% and 54%
being resistant to at least one drug. Among the 53 M. africanum
isolates studied, one only was MDR and 17 (32%) were resistant
to one of the drugs tested. The proportion of MDR was higher
among the H family (28%, 9 out of 32).
Spatial and Phylogenetical Analysis of Diversity and
Transmission
To detect if specific MTBC clusters were circulating in specific
geographical areas, cluster analyses were performed independently
for each collecting center (Figures 2, 3 and 4 for Abuja, Ibadan, and
Nnewi, respectively). The number of clustered isolates of the 3
centers was reduced to72 ascompared to 134inthe complete study
(54%)whenconsidering100%identity,and144ascomparedto219
(66%) when allowing for inclusion of SLVs. The prevalence of the
main clades was similar in the three cities (p=0.59). These results
confirmthatNigeriacanbeconsideredashomogeneousinthethree
settings investigated regarding the origin of isolates. A linear model
was searched for to identify possible differences in transmission
depending on the city (Abuja, Ibadan, Nnewi) or large isolate
families (CAM, other modern isolates, other isolates namely M.
africanumandM.bovis).Thecladewasfoundtobesignificantlylinked
to the transmission frequency as assessed by clustering, with higher
transmission for T isolates (ANOVA, p=0.012; effect sizes: ‘‘M.
africanum and bovis’’ family=-0.25; ‘‘CAM’’ family=20.01; other
modern isolates [T]=+0.32). Indeed T isolates exhibited the lower
proportion of orphans (59% as compared to 94% for M. africanum
and M. bovis cluster and 87% for CAM). No significant statistical
differences were detected regarding transmission in the different
centers although a tendency for higher transmission in Abuja and
Nnewi was detected (Table 3).
Discussion
This is the largest and most detailed genetic characterisation on
MTBC clinical isolates of patients suffering from TB in Nigeria
relying on the analysis of isolates from three main cities [2]. The
genetic diversity of MTBC was characterised by spoligotyping (43
and 68 spacers) and by 24 VNTR loci [10,27].
Spoligotyping is a genotyping method that studies the genetic
diversity of the Clustered Regularly Interspersed Palindromic
Repeats (CRISPR) within the MTBC (for a review on CRISPR
see [28]). It enables reliable subspecies identification [17,29,30]. Its
recent transfer from a membrane-based to a microbead-based
format resulted in a second youth to this method, and a similar
‘‘CRISPOL’’ method has recently been developed to track
outbreaks for another pathogen, Salmonella enterica ser. typhimur-
ium [9,15,31].
Increasing the number of spacers to be analysed in some settings
can also improve clustering and reduce the costs of systematic
Spoligo+VNTR typing as recently shown in Cambodia where the
number of VNTR locus to be analysed was reduced to 8 without
loss of discriminatory power [32].
We have shown in this study that the recent tuberculosis
transmission rate could be between 22 and 38% using either a
strict (100% identity on 24 VNTR) or smooth (including SLV)
definition of clusters. We detected an active transmission of TB
especially in Abuja and Nnewi, although these data need to be
interpreted with caution given the short (one year) recruitment
period [33]. However, looking into the social network of patients
found in clusters could not be done here and is a clear limitation of
this study.
The CAM genotypes were the most prevalent circulating
genotypes (66%). This clade was first described in Cameroon,
where it represented 34% of the M. tuberculosis isolates in 2003
[25]. This group of strains was assumed to have emerged
recently and homogeneously in the West province of Cameroon.
It is characterized by the SIT61 signature (spacers 23–25 and
33–36 missing) and a homogenous 6 bands-Ligation-Mediated
PCR pattern [25]. The CAM clade belongs to the principal
genetic group 2 (i.e. modern strains) and is lacking the TbD1
region [26]. Several CAM spoligotype variants (SIT852, SIT808,
SIT403) have been reported in Cameroon and in Nigeria [26].
The 12 MIRU-VNTR signatures differ in 4 out of 12 loci
(MIRU16, MIRU26, MIRU27, MIRU40) and they have similar
IS6110-RFLP patterns (10 to 15 copies) with seven common
bands [26]. This group was also shown not to have an IS6110
copy in the DR locus and four IS6110 copies in open reading
frames coding for adenylate cyclase, phospholipase C, moeY, and
ATP-binding proteins [26]. In rare cases, strains with identical
IS6110-RFLP patterns had spoligotypes differing by as much as
15 spacers [26].
Figure 3. Unweighted Pair Group Method using Mathematical Averages (UPGMA) dendrogram (first column) built with
BionumericsH on a composite data set (24 VNTR-largest column)-Spoligotyping (coloured column) on the clinical isolates from
Ibadan patients. (identification number : last column) Main Clades are also annotated right to identification number.
doi:10.1371/journal.pone.0038409.g003
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e38409Figure 4. Unweighted Pair Group Method using Mathematical Averages (UPGMA) dendrogram (first column) built with
BionumericsH on a composite data set (24 VNTR-largest column)-Spoligotyping (coloured column) on the clinical isolates from
Nnewi patients. (identification number : last column) Main Clades are also annotated right to identification number.
doi:10.1371/journal.pone.0038409.g004
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38409In a recent study, four clinical isolates belonging to the
Cameroon clade were partially sequenced to detect single
nucleotide polymorphisms (SNPs) and in an attempt to find new
markers for molecular evolution and epidemiology. A specific non-
synonymous mutation in the dnaQ gene was found in these four
isolates of the CAM clade [34]. Whether this SNP could be used to
specifically identify the CAM clade remains to be studied on a
large sample in West Africa. The CAM clade had formerly been
designated as a subclade of the LAM clade (LAM10-CAM) based
on the common absence of spacers 23–24 [17]. However Dos
Vultos and colleagues demonstrated that this clade has nothing to
do with bona fide LAM, since it does not carry the LAM-specific
SNPs [34].
In addition to Cameroon, a high prevalence of the CAM clade
had been previously observed in neighbouring countries such as
Chad (33%), Burkina Faso (30%) and Ghana (45%) [14,25,35–37]
and a study on the genetic diversity of TB in Jos, Plateau state
(Nigeria) suggested a frequency of this clade similar to the one
found here [3]. Thus our study indicates that the CAM clade has a
very high prevalence in Nigeria and suggests that Nigeria is the
present largest reservoir for this genetic family in Africa.
M. africanum remains an important cause of TB in humans.
Its presence in every setting of this study confirms that it is still
transmitting in Africa. Its capacity to spread and to cause
disease seems restricted though [38]. Here, the lower frequency
of recent transmission was further documented for subfamily M.
africanum West African 1 as all M. africanum isolates but one in
Abuja belonged to this type [21]. Its continuing presence could
however be due to different transmission dynamics, namely the
ability to perform efficient retarded transmission. This possibility
could be investigated using long-term molecular epidemiological
studies.
Four Spoligotype profiles characteristic of M. bovis isolates were
found in Abuja, which is in the Central North area where the
population owns large herds of cattle. As in a previous study all
belonged to the M. bovis Afri1 family that was found to infect
human, cattle, goat and pigs [5]. Another former study of 55
isolates from human samples in Ibadan (South-West) revealed
11% of M. bovis Afri1 and zero Afri2 [39].
Regarding transmissibility of the different families, the fact that
the CAM clade is very prevalent is an indirect evidence of a high
fitness. VNTR3690 (Mtub39) copy number was very variable in
this clade. Mtub39 is located in the promoter of the lpdA gene, a
potential virulence factor. The number of repetitions in Mtub39
was found correlated to the expression level of lpdA [22].
Patho-physiological grounds on the success of the CAM clade
could also be linked to the polymorphism of the 3R genes. Until
now, we have no evidence of such a link although it is likely that
Table 1. Main spoligotyping clusters, orphan isolates and new variants within the Cameroon (CAM) (A) M. bovis (B), and
M. africanum (C) genotype families found in this study.
SIT Spoligotype binary Spoligotype Octal
n6 of
Strains
A 61 777777743760771 208
838 777777743760751 19
403 777777743760731 4
852 400003743760771 3
2550 777737743760771 3
NEW15* 777777743760700 7
NEW14* 777777743740771 2
NEW13* 777770343740771 4
NEW12* 776777743760771 4
NEW6* 757777743760771 4
NEW4* 677777743760771 3
B 1037 676773777677600 1
new-h* 646773777677600 1
new-d* 476773777677600 1
new-b* 276773777677600 1
C 320 770007414777071 2
330 774077607777031 3
331 774077607777071 13
NEW1* 074077607777071 2
NEW2* 374077600000000 2
NEW8* 774003607777071 5
NEW10* 774021600006071 5
NEW11* 774077600000031 4
NEW16* 774077607377071 2
In column B, a star (*) appears next to the « NEW » label when no Spoligo-International-Type (SIT) number was available within the international database SpolDB4.
SIT1037 is also designated as SB0944 in the M. bovis.org database (SB nomenclature), new-h is identical to SB1026, new-d is identical to SB1099, whereas new-b has no
SB number.
doi:10.1371/journal.pone.0038409.t001
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evolution [40,41]. Alternatively, the main parameter responsible
for the fitness of the CAM clade may be the demographic
changes of the Nigerian population with a population of around
150 million in 2012 and a projected 250 million population in
2035.
Even though we did not observe strong geographical
differences in the prevalence of the clades in the three cities,
further analysis of data stratified by language and ethnic/tribe
group and a more thorough spatial analysis may allow to better
investigate bacterial genotypes-human hosts associations. Further
work to characterise the phenotypic/genotyping links within M.
tuberculosis strains circulating in Nigeria is also needed, especially
on the critical issue of MDR-XDR-TB control. In this sense,
new studies that will use integrated molecular methods, aimed
at both MDR-TB prevention, outbreak surveillance and patient
care should be implemented in Nigeria in a near future.
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